In September 2013, the FDA released new labeling pointers for prolonged acting and prolonged release opioids requiring suppliers to remove reasonable pain as indication to be used, rather stating the drug is for "agony critical sufficient to call for daily, all around-the-clock, long-term opioid therapy".Never share prescription opioid ache medicat